The Importance of Accurate Staging in Prostate Cancer

Video Library —January 19, 2022
Neal D. Shore, MD
Carolina Urologic Research Center, Myrtle Beach, SC
Dr Neal Shore emphasizes the importance of accurate staging of prostate cancer and how PYLARIFY® (piflufolastat F 18) can improve treatment decision-making in patients with prostate cancer.
Related Articles
Insights into the Prostate Cancer Imaging Landscape
Steven Rowe, MD, PhD
|
Video Library
Dr Steven Rowe continues his discussion of PYLARIFY® (piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients.
Results from the OSPREY Trial in Pre-Prostatectomy Patients
Steven Rowe, MD, PhD
|
Video Library
Dr Steven Rowe continues his discussion of PYLARIFY® (piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients.
PYLARIFY Imaging in High-Risk Prostate Cancer
Steven Rowe, MD, PhD
|
Video Library
Dr Steven Rowe expands on the sensitivity and specificity of PYLARIFY® (piflufolastat F 18) imaging in high-risk prostate cancer.
Last modified: January 26, 2022

Subscribe to the Journal of Oncology Navigation & Survivorship®

To sign up for our print publication or e-newsletter, please enter your contact information below.

  • First Name *
    Last Name *
     
     
    Profession or Role
    Primary Specialty or Disease State
    Country
  • Please enter your mailing address.

    Address
     
    Address Line 2
    City
     
    State
    Zip Code